Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioventus (BVS) Gains from Investment Securities (2020 - 2024)

Bioventus' Gains from Investment Securities history spans 5 years, with the latest figure at $1.4 million for Q4 2024.

  • For Q4 2024, Gains from Investment Securities rose 390.69% year-over-year to $1.4 million; the TTM value through Sep 2025 reached $1.4 million, up 4.02%, while the annual FY2024 figure was $1.4 million, 97.91% up from the prior year.
  • Gains from Investment Securities reached $1.4 million in Q4 2024 per BVS's latest filing, up from $483000.0 in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $3.4 million in Q2 2022 to a low of -$2.2 million in Q4 2022.
  • Average Gains from Investment Securities over 5 years is $421133.3, with a median of $290000.0 recorded in 2023.
  • Peak YoY movement for Gains from Investment Securities: crashed 135.25% in 2023, then soared 592.86% in 2024.
  • A 5-year view of Gains from Investment Securities shows it stood at $152000.0 in 2020, then soared by 328.29% to $651000.0 in 2021, then crashed by 445.62% to -$2.2 million in 2022, then surged by 112.89% to $290000.0 in 2023, then soared by 390.69% to $1.4 million in 2024.
  • Per Business Quant, the three most recent readings for BVS's Gains from Investment Securities are $1.4 million (Q4 2024), $483000.0 (Q3 2024), and $300000.0 (Q2 2024).